Medicare Bone Density Test Coverage: Who Qualifies, How Often, and What You Pay
Medicare Part B covers a bone density test once every 24 months, and you pay nothing for the test itself if the provider accepts assignment. There's no Part B deductible on it and no 20% coinsurance. But it isn't automatic for everyone on Medicare. You have to fit at least one of five medical conditions, and your treating doctor or practitioner has to order it.
The first condition is for women whose doctor finds them estrogen-deficient and at clinical risk for osteoporosis. Men can qualify too, through a different door. And the 24-month clock is shorter than it sounds, because the federal rule actually counts 23 months, not two full years.
Source: Medicare.gov, Bone mass measurements; 42 CFR 410.31(c); 42 CFR 410.160(b)(10); CMS 2027 Parts A & B fact sheet.
The five ways to qualify
Medicare calls it a "bone mass measurement." Your doctor will probably call it a DEXA or DXA scan, short for dual-energy X-ray absorptiometry. The regulation, 42 CFR 410.31, defines the benefit as a test that measures bone mass, detects bone loss or determines bone quality, done with a bone densitometer or an FDA-cleared bone sonometer, and it includes a physician's interpretation of the results. Two older methods, single-photon and dual-photon absorptiometry, are not covered (Benefit Policy Manual, ch. 15, sec. 80.5.7).
You need to meet one or more of these conditions. Medicare.gov uses plain language; the regulation adds detail that matters when a claim gets questioned.
| Condition | What Medicare.gov says | What the regulation adds |
|---|---|---|
| 1. Estrogen deficiency | A woman whose doctor determines she's estrogen-deficient and at risk for osteoporosis, based on medical history and other findings | "At clinical risk." The determination is made by the treating physician or qualified nonphysician practitioner. Women only. |
| 2. X-ray findings | X-rays show possible osteoporosis, osteopenia or vertebral fractures | Vertebral abnormalities on an x-ray indicative of osteoporosis, osteopenia or vertebral fracture |
| 3. Steroid treatment | Taking prednisone or steroid-type drugs, or planning to begin | Glucocorticoid therapy equal to an average of 5.0 mg of prednisone or more per day, for more than 3 months |
| 4. Hyperparathyroidism | Diagnosed with primary hyperparathyroidism | Same |
| 5. Drug monitoring | Being monitored to see if osteoporosis drug therapy is working | The drug must be FDA-approved for osteoporosis, and the monitoring test must be an axial DXA |
Source: Medicare.gov, Bone mass measurements; 42 CFR 410.31(b) and (d).
Condition 1 is the women's route, and it's broader than it sounds. CMS tells contractors that a woman taking estrogen replacement therapy can still qualify, because not every dose is "adequate." What CMS expects in return is paperwork: the ordering practitioner should document in your medical record why you're estrogen-deficient and at clinical risk (Benefit Policy Manual, sec. 80.5.6).
That documentation matters. If a test is ordered without a qualifying reason in the chart, the regulation says it's excluded as not "reasonable and necessary." So if you're asking for the test, tell your doctor why you think you're at risk, and ask them to note it.
One more requirement people miss: the order has to come from the physician or practitioner who is treating you and will use the result. Under the CMS manual that can be a doctor, physician assistant, nurse practitioner, clinical nurse specialist or certified nurse midwife (sec. 80.5.4). A walk-in scan with no order from your own clinician isn't the Part B benefit.
Can men get a covered bone density test?
Yes, if they meet one of conditions 2 through 5. Only the first condition is limited to women. The other four say "an individual" in the regulation, so a man on long-term prednisone, a man whose spine X-ray shows osteopenia, a man with primary hyperparathyroidism, or a man taking an FDA-approved osteoporosis drug can all have the test covered.
What Medicare doesn't cover is routine screening of men with no qualifying condition. That lines up with the U.S. Preventive Services Task Force, which says the evidence is insufficient to weigh the benefits and harms of screening men (USPSTF, 2025). If you're a man and your doctor thinks you need the test, ask which condition applies before you schedule it.
How often: the 23-month count
Medicare.gov says "once every 24 months." The regulation is more precise: Medicare may cover the test if at least 23 months have passed since the month your last bone density test was done (42 CFR 410.31(c)(1)). The day of the month doesn't matter. That gives you a little room when scheduling, and it's why a scan two years later almost to the day is normally fine.
| Last covered test | Earliest month the next one is covered |
|---|---|
| March 2025 | February 2027 |
| November 2025 | October 2027 |
| January 2026 | December 2027 |
Source: computed from 42 CFR 410.31(c)(1): month of last test plus 23 months.
The "more often if medically necessary" part is real, and the regulation gives two examples, while saying the list isn't exhaustive:
- Long-term steroids. Monitoring someone on glucocorticoid therapy for more than 3 months.
- A confirmatory baseline. If your first test was done on something other than an axial DXA machine (an ultrasound bone sonometer, for example), Medicare can cover a confirming DXA so future tests compare like with like. If the first one already was an axial DXA, a confirmatory baseline isn't covered.
Outside those situations, an early repeat needs a medical reason your doctor documents. If the office can't tell you why the test qualifies before the 23 months are up, expect to pay for it yourself. Medicare.gov's own warning on this page applies: your doctor may recommend services Medicare doesn't cover or covers less often, so ask what Medicare will actually pay for (Medicare.gov).
What you pay, and where the bills come from
Bone mass measurement is on Medicare's preventive services list, and two federal rules make the test itself cost nothing out of pocket when the provider accepts assignment. Part B pays 100% of the Medicare payment amount for it (42 CFR 410.152(l)(6)), and it's exempt from the Part B deductible (42 CFR 410.160(b)(10)).
"Accepts assignment" means the provider takes the Medicare-approved amount as payment in full. A non-participating provider can charge more than that, in many cases up to 15% above the approved amount (the "limiting charge"), and may ask you to pay the whole bill at the visit. Medicare won't pay an opted-out provider, except in emergencies (Medicare.gov). Ask the imaging center one question before you book: do you accept Medicare assignment?
| What happens | What Original Medicare pays | What you pay |
|---|---|---|
| The bone density test (you qualify, provider accepts assignment) | 100% of the approved amount | Nothing; no deductible |
| Test with a non-participating provider | Its share of the approved amount | The amount over Medicare's payment, up to the limiting charge (generally 15% above the approved amount); you may have to pay up front |
| Test too soon, with no documented medical reason | Nothing (not reasonable and necessary) | The full cost |
| Follow-up office visit to go over results or start treatment | 80% after the deductible | Part B deductible ($292 in 2027), then usually 20% |
| Osteoporosis injection given at home by a home health nurse (if eligible) | The nurse visit; the drug after the deductible | Nothing for the nurse visit; up to 20% for the drug after the deductible |
Source: Medicare.gov, Bone mass measurements; Medicare.gov, provider assignment; Medicare.gov, Osteoporosis drugs; 42 CFR 410.31(e); CMS 2027 fact sheet.
The follow-up visit is where costs show up. That visit is ordinary Part B care, so the deductible and coinsurance apply. CMS set the 2027 Part B deductible at $292, up $9 from $283 in 2026 (CMS). More on that in the 2027 Part B premium and deductible.
Example (hypothetical): say your DXA in February 2027 shows osteoporosis, and the follow-up visit has a Medicare-approved amount of $400. You haven't met the deductible yet that year. The scan costs you nothing. For the visit, you pay the first $292, then 20% of the remaining $108, which is $21.60. Total for the visit: $313.60. Real approved amounts vary by service and location; the point is the math, not the price.
Source: 2026 Medicare Trustees Report, Table V.E2 (2021–2026); CMS 2027 fact sheet (2027)
Show the numbers
| Part B deductible | |
|---|---|
| 2021 | $203 |
| 2022 | $233 |
| 2023 | $226 |
| 2024 | $240 |
| 2025 | $257 |
| 2026 | $283 |
| 2027 | $292 |
Medicare Advantage and Medigap
Medicare Advantage. Every Medicare Advantage plan has to cover the medically necessary services Original Medicare covers (Medicare & You 2027), and federal rules bar plans from charging a deductible, copay or coinsurance for in-network Medicare-covered preventive services, which includes bone mass measurement (42 CFR 422.100(k)). The words "in network" carry the weight there. Out-of-network imaging, or a test the plan needs to authorize first, can play out differently, so call the number on your member card before you book and ask whether the imaging center is in network and whether anything needs approval.
Medigap. A Medicare Supplement policy helps pay your share of costs in Original Medicare, like coinsurance and deductibles (Medicare.gov). It doesn't change the test, which already costs you nothing with assignment. Where Medigap can matter is the follow-up: the 20% on visits and on Part B osteoporosis drugs. See Medicare Supplement insurance in Florida for how those policies work here.
If the test finds osteoporosis
A diagnosis moves you from preventive care to treatment, and the cost rules change with it. Repeat scans to check whether an FDA-approved osteoporosis drug is working are covered under condition 5, on an axial DXA, on the usual 23-month cycle unless your doctor documents a reason for more frequent testing.
There's also a narrow benefit worth knowing about. Medicare Part A and Part B cover certain injectable osteoporosis drugs, plus the home health nurse visits to give the injections, for a woman with osteoporosis who meets all of these conditions (Medicare.gov):
- She meets the criteria for Medicare home health services, which includes being homebound.
- She has a bone fracture that a doctor or other provider certifies is related to postmenopausal osteoporosis.
- Her provider certifies she can't give herself the injection or learn how, and family members or caregivers are unable or unwilling to do it.
"Homebound" has a specific meaning: leaving home isn't recommended because of your condition, or you need help to leave (a walker, a wheelchair, special transportation, another person), and leaving normally takes a lot of effort (Medicare.gov, Home health services). A provider has to see you in person and order the care, and a Medicare-certified home health agency has to provide it. Here's more on Medicare home health coverage.
On cost: you pay nothing for the nurse visit to inject the drug. For the drug itself, in most cases you pay up to 20% of the Medicare-approved amount after the Part B deductible, and Medicare.gov notes the coinsurance can be lower for some Part B drugs whose prices rose faster than inflation (Medicare.gov).
Screening guidelines are not Medicare rules
You'll hear "every woman should get a bone density test at 65." That comes from the U.S. Preventive Services Task Force, an independent panel whose recommendations, by its own description, are not an official position of the federal government. Its current osteoporosis recommendation is dated January 14, 2025.
| Group | USPSTF (Jan. 14, 2025) | Medicare Part B |
|---|---|---|
| Women 65 and older | Screen (grade B) | Covered when a qualifying condition applies, such as estrogen deficiency documented by the treating clinician |
| Postmenopausal women under 65 at increased risk | Screen (grade B), after a risk assessment | Covered if a qualifying condition applies, including for people under 65 on Medicare |
| Men | Evidence insufficient (I statement) | Covered only under conditions 2–5 (X-ray findings, steroids, hyperparathyroidism, drug monitoring) |
| People on long-term steroids | Outside the recommendation's scope (secondary osteoporosis) | Covered under condition 3; more frequent testing can be medically necessary |
Source: USPSTF, Osteoporosis to Prevent Fractures: Screening (2025); 42 CFR 410.31.
The 2025 update mostly kept the 2018 recommendation and spelled out that screening means a DXA bone mineral density test, with or without a fracture-risk assessment. The practical takeaway: the guideline tells your doctor who should be screened. Medicare's rule tells the claim why this particular person qualifies. For a woman 65 or older, those two usually meet, but only if the reason is written down.
Getting it ordered, and help in Florida
The easiest place to bring it up is a preventive visit you're already entitled to. The one-time "Welcome to Medicare" visit, in your first 12 months with Part B, and the yearly Wellness visit after that both end with a written checklist of the screenings and preventive services you need (Medicare.gov, Medicare.gov). Ask that bone density be on it, and ask which condition the order will use. Bone density sits alongside mammograms, colonoscopy screening and the rest in the full list of Medicare preventive services.
Before the appointment, have answers to four questions:
- Which of the five conditions applies to me, and is it in my chart?
- When was my last bone density test, and have 23 months passed since that month?
- Does the imaging center accept Medicare assignment (or, with Medicare Advantage, is it in network)?
- If the results lead to a follow-up visit or a drug, what will I owe under Part B?
If a Medicare Summary Notice shows a charge for the test that doesn't match those answers, get a second set of eyes on it. Florida's SHINE program (Serving Health Insurance Needs of Elders), offered by the Florida Department of Elder Affairs and the local Area Agencies on Aging, gives one-on-one Medicare counseling at no charge, and preventive benefits are on its list of topics (floridashine.org; Elder Affairs). Call 1-800-963-5337 (TTY 1-800-955-8770). Here's more on how SHINE counseling works. You can also call 1-800-MEDICARE (1-800-633-4227), TTY 1-877-486-2048. For the bigger picture, see Medicare coverage in Florida.
Your own coverage documents and Medicare's rules decide how any claim is paid. Confirm your situation with a licensed agent, SHINE, 1-800-MEDICARE or, for legal questions, an attorney.
Sources
- Medicare.gov: Bone mass measurements
- Medicare.gov: Osteoporosis drugs
- Medicare.gov: Home health services
- Medicare.gov: "Welcome to Medicare" preventive visit
- Medicare.gov: Yearly "Wellness" visits
- Medicare.gov: Does your provider accept Medicare as full payment?
- Medicare.gov: Medicare costs
- Medicare.gov: What's Medicare Supplement Insurance (Medigap)?
- CMS: Medicare & You 2027
- eCFR: 42 CFR 410.31, Bone mass measurement
- eCFR: 42 CFR 410.152, Amounts of payment
- eCFR: 42 CFR 410.160, Part B annual deductible
- eCFR: 42 CFR 422.100, General requirements (Medicare Advantage)
- CMS: Medicare Benefit Policy Manual, Chapter 15, sec. 80.5
- CMS: NCD 150.3, Bone (Mineral) Density Studies
- CMS: 2027 Medicare Parts A & B Premiums and Deductibles fact sheet
- CMS: 2026 Medicare Trustees Report
- U.S. Preventive Services Task Force: Osteoporosis to Prevent Fractures: Screening (2025)
- Florida SHINE
- Florida Department of Elder Affairs: 2025 Year in Review
This article is for general educational purposes only and is not legal, tax or insurance advice. Coverage depends on the actual policy, its terms, conditions and exclusions, and state law. Maru Insurance · WA License (WAOIC) #1365574 · FL License #G363233 · NPN 22261820.